ClinicalTrials.Veeva

Menu

The Efficacity of Hemodiafiltration Versus Hemofiltration for Renal Insufficiency During Intensive Care

C

Centre Hospitalier Universitaire de Nīmes

Status

Completed

Conditions

Renal Failure, Acute

Treatments

Procedure: Hemodiafiltration first
Procedure: Hemofiltration first

Study type

Interventional

Funder types

Other

Identifiers

NCT01403220
2011-A01550-41 (Other Identifier)
LOCAL/2011/PJ-02

Details and patient eligibility

About

The primary objective of this study is to compare the efficacity of hemodiafiltration and hemofiltration for decreasing plasma urea at 12h among intensive care patients. Secondary objectives include comparing urea clearance, filter duration, and %down-time, between the two techniques.

Enrollment

163 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • According to RIFLE score, patient is stage 'F'
  • The patient must be insured or beneficiary of a health insurance plan
  • The patient meets at least one of the following criteria:
  • metabolic acidosis (pH < 7.2), excluding keto-acidosis
  • plasma urea > 25 mmol/l
  • hyper-hydration is not controlled by diuretics

Exclusion criteria

  • Chronic, terminal renal insufficiency with dialysis
  • The patient is under judicial protection, under tutorship or curatorship
  • Suspect hyperkaliemia (Kaliemia > 6.5 mmol/l with electrocardiographic effects)
  • Intoxications treated via dialysis
  • Pregnant, lactating, parturient women
  • Medical indication for localized citrate anticoagulation
  • dialysis of less than 12 h
  • patient or representative refuses to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

163 participants in 2 patient groups

Group 1 (hemodiafiltration first)
Active Comparator group
Description:
This group of patients will alternate consecutive dialysis sequences between hemodiafiltration and hemofiltration, but starting with hemodiafiltration.
Treatment:
Procedure: Hemodiafiltration first
Group 2 (hemofiltration first)
Active Comparator group
Description:
This group of patients will alternate consecutive dialysis sequences between hemodiafiltration and hemofiltration, but starting with hemofiltration.
Treatment:
Procedure: Hemofiltration first

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems